Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 2
1995 3
1996 1
1997 3
1998 1
1999 1
2000 1
2001 1
2003 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Expression and androgenic regulation of human prostate-specific kallikreins.
Young CY, Andrews PE, Tindall DJ. Young CY, et al. J Androl. 1995 Mar-Apr;16(2):97-9. J Androl. 1995. PMID: 7559150 Free article. Review.
Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells.
Chung BH, Mitchell SH, Zhang JS, Young CY. Chung BH, et al. Carcinogenesis. 2001 Aug;22(8):1201-6. doi: 10.1093/carcin/22.8.1201. Carcinogenesis. 2001. PMID: 11470750
Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC. Spitzweg C, et al. Endocrinology. 2003 Aug;144(8):3423-32. doi: 10.1210/en.2002-0206. Endocrinology. 2003. PMID: 12865321
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
Young CY, Andrews PE, Montgomery BT, Tindall DJ. Young CY, et al. Biochemistry. 1992 Jan 28;31(3):818-24. doi: 10.1021/bi00118a026. Biochemistry. 1992. PMID: 1370633
Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate.
Paschka AG, Butler R, Young CY. Paschka AG, et al. Cancer Lett. 1998 Aug 14;130(1-2):1-7. doi: 10.1016/s0304-3835(98)00084-6. Cancer Lett. 1998. PMID: 9751250
Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Butler R, Mitchell SH, Tindall DJ, Young CY. Butler R, et al. Cell Growth Differ. 2000 Jan;11(1):49-61. Cell Growth Differ. 2000. PMID: 10672903 Free article.
Effects of Ca++ mobilization on expression of androgen-regulated genes: interference with androgen receptor-mediated transactivation by AP-I proteins.
Murtha PE, Zhu W, Zhang J, Zhang S, Young CY. Murtha PE, et al. Prostate. 1997 Dec 1;33(4):264-70. doi: 10.1002/(sici)1097-0045(19971201)33:4<264::aid-pros7>;2-h. Prostate. 1997. PMID: 9397199
A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells.
Zhu W, Smith A, Young CY. Zhu W, et al. Endocrinology. 1999 Nov;140(11):5451-4. doi: 10.1210/endo.140.11.7246. Endocrinology. 1999. PMID: 10537180
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients.
Holmes EH, Greene TG, Tino WT, Boynton AL, Aldape HC, Misrock SL, Murphy GP. Holmes EH, et al. Prostate Suppl. 1996;7:25-9. Prostate Suppl. 1996. PMID: 8950359
Antagonism of androgen action in prostate tumor cells by retinoic acid.
Young CY, Murtha PE, Andrews PE, Lindzey JK, Tindall DJ. Young CY, et al. Prostate. 1994 Jul;25(1):39-45. doi: 10.1002/pros.2990250106. Prostate. 1994. PMID: 8022710
17 results
Jump to page